02:46 PM EST, 01/13/2025 (MT Newswires) -- Blue Owl Capital (OBDC) is leading a $4 billion private credit deal for privately-held PCI Pharma Services, Bloomberg reported Monday, citing people familiar with the matter.

The transaction includes about $3 billion unitranche loan to refinance existing debt, and over $1 billion delayed-draw term loan, but the size of the term loan could still change, the people reportedly said.

The pricing of secured overnight financing rate plus 4.75% is under discussion, according to the people.

Neither Blue Owl nor PCI Pharma immediately responded to MT Newswires' requests for comment.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 14.79, Change: +0.23, Percent Change: +1.62